Skip to main content
. 2020 Mar 13;11(12):3446–3453. doi: 10.7150/jca.41135

Figure 3.

Figure 3

The dose-dependent effects of miR-186 on cisplatin sensitivity in other types of cancer cells. Transfected cells (including SKBR3, HepG2, A549 and HCT116 cells) with different concentrations of miR-186 mimic or NC, were exposed to cisplatin at the concentration of 20uM, and cell viability was analyzed 48 hours later. *P<0.05, **P<0.01, ***P<0.001.